Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Maufras Du Chatellier, Elyssa

Investment Director

Charlotte Corbaz

Investment Drector - Large Venture

Dahoune, Sofia

Associate

Vanessa Giraud

Director of Environmental Impact Funds

Gwenaël Hamon

Investment Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Jacq, Véronique

Head of Digital Venture team

So-Yeon Koo

Senior Investment Manager

Eric Lefebvre

Director

Legardeur, Arnaud

Investment Director

Serge Mesguich

Director of FIT

Louis Molis

Investment Director

Adrien Neel

Investment Director

Gilles Schang

Deputy Managing Director

Past deals in France

Expliseat

Venture Round in 2023
Expliseat is a manufacturer specializing in lightweight aircraft seats, most notably the Titanium Seat, which weighs only 4 kg. This innovative design significantly reduces fuel consumption, yielding potential savings of up to $500,000 per aircraft annually. The seats are crafted from carbon fiber and feature a unique hinge mechanism, ensuring durability while accommodating passengers of all sizes. With ten patents to its name, Expliseat's products also enhance passenger comfort by providing two additional inches of legroom, catering to the evolving needs of airlines and their customers.

Odimma

Seed Round in 2023
Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

EyeLights

Series A in 2023
EyeLights is a Head Up Display GPS. It allows motobikers to truly experience the ride by keeping their eyes on the road. Eyelights is the first universal motorcycle accessory that projects guidance, danger zones and traffic directly into your field of vision. A dangerous bend, a nearby stopper or speed over limitations, EyeLights warns you. Simple, uncluttered, they adapted the display for motorcycle riding. The EyeLights product installs in less than 5 minutes on your full-face, convertible or jet helmet. Their compact optical technology allows you to view your GPS more than 2 meters away while enjoying audio functions for more than 8 hours. The product is compatible with sun visors, insensitive to rain or fog and weighs less than 100g.

Kiro

Series A in 2023
Operator of a digital medicine company intended to provide insights on laboratory test results that are understandable to patients. The company fosters the interactions between laboratories, health professionals and patients and goes beyond results in patient care through the use of new technologies and artificial intelligence, enabling medical professionals to easily interpret and diagnose in a personalized and effective way.

Exotrail

Series B in 2023
Exotrail develops electric propulsion solutions for small satellites. Their safe and efficient Hall Effect Thrusters are helping build agile constellations to revolutionize telecommunication, earth observation, space, and science. David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz co-founded the company in Palaiseau, Ile-de-France in 2015.

Dianosic

Seed Round in 2023
Dianosic SAS, founded in 2017 and based in Strasbourg, France, specializes in developing advanced medical devices for Ear, Nose, and Throat (ENT) conditions. The company has created CAVI-T, an innovative intranasal balloon designed to stop spontaneous or postoperative bleeding through low-pressure compression, while also preventing biofilm formation and enhancing healing. Additionally, Dianosic is working on the Active Resorbable Intranasal Scaffold (ARIS), a groundbreaking treatment for chronic sinusitis and allergic rhinitis, which offers a long-lasting drug-eluting solution that can last from six to twelve months. This technology not only addresses patient compliance challenges but also presents opportunities for expanding treatment options in related areas such as chronic migraine and facial pain. Through its cutting-edge solutions, Dianosic aims to redefine standards of care in ENT healthcare.

Garantme

Series B in 2023
Garantme gives access to thousands of international students in France by guaranteeing their lease and boosting their application.

ATAWEY

Private Equity Round in 2023
ATAWEY, founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, specializes in designing and manufacturing autonomous energy solutions specifically for isolated sites. The company employs established French technologies to provide innovative and sustainable energy products tailored to the unique needs of each client. ATAWEY focuses on delivering turnkey power supply systems, including hydrogen refueling stations, which offer a clean and reliable alternative to traditional energy sources. By addressing the challenges of energy availability in remote locations, ATAWEY ensures that businesses can access green energy even in situations where batteries may be depleted and diesel options have a substantial carbon footprint. The company is committed to project management that emphasizes adaptability, reliability, and environmental responsibility, aiming for economic viability and quick returns on investment for its clients.

PASQAL

Series B in 2023
PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

Agenium

Venture Round in 2023
Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.

Mycophyto

Venture Round in 2023
Mycophyto, co-founded in July 2016 by microbiologist Justine Lipuma and Senior Research Engineer Christine Poncet-Doise, specializes in biological crop protection based on three decades of research. The company develops customized products and offers specific support services to facilitate innovative agricultural systems. Mycophyto's plant production system focuses on identifying indigenous fungi and beneficial soil pathogens that enhance plant growth. By cultivating these microorganisms in an integrated greenhouse, the company enables researchers to grow a variety of plants, crops, and herbs sustainably, reducing dependence on chemical fertilizers. Through its unique approach, Mycophyto aims to advance agricultural practices while promoting environmental sustainability.

Odaptos

Seed Round in 2023
Odaptos specializes in developing a software-as-a-service (SaaS) platform that facilitates usability testing in videoconferencing environments. This artificial intelligence-driven solution analyzes human emotions and user behavior, delivering comprehensive insights that help businesses understand their end-users. The platform streamlines the usability testing process by visually highlighting critical moments during interviews, thereby saving time and allowing for a more efficient evaluation of the user journey. Through its innovative approach, Odaptos aims to enhance user experience and optimize product development based on real-time feedback and analysis.

45-8 ENERGY

Seed Round in 2022
45-8 Energy SAS, founded in 2017 and based in Metz, France, specializes in the exploration and production of eco-friendly helium. The company conducts subsurface exploration to extract helium and engages in research and development projects to identify helium and its associated resources. By focusing on eco-friendly practices, 45-8 Energy aims to provide a local helium supply chain for various industries, thereby minimizing the environmental impact typically associated with helium extraction. Additionally, the company offers consulting services in oil and gas, further enhancing its role in the energy sector.

Kumulus Water

Pre Seed Round in 2022
Kumulus is the water utility company of the future with the mission of making drinking water accessible for all in a more economical and sustainable way. Kumulus builds machines that turn air into fresh mineralized drinking water.

Guerbet

Post in 2022
Guerbet is a human-scale company that aims to become a new global leader in medical imaging. Pioneer in contrast media with 90 years'​ experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors. The company offers a comprehensive range of CT scan, Cath Lab, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostic (IRT) products, along with a range of injectors and related medical devices to improve patients'​ diagnosis, prognosis and quality of life.

ChapsVision

Venture Round in 2022
ChapsVision specializes in providing a data analysis platform that addresses complex business challenges for sectors with significant data footprints, such as Retail, Finance, and Public Services. The company offers a comprehensive suite of business solutions that are fully integrated around a unified Customer and Product repository. This modern analytical infrastructure equips clients with intelligence, investigation, and analysis tools that consolidate data from various sources into a single workspace. By doing so, ChapsVision supports its customers in effectively navigating and optimizing their digital transformation processes.

Devialet

Venture Round in 2022
Devialet is an audio technology company based in Paris, founded in 2007, that specializes in developing advanced acoustic engineering solutions. The firm offers a range of audio equipment, including connected speakers and wireless earbuds, such as its Gemini model. By integrating digital and analog technologies, Devialet aims to enhance the audio experience for consumers. The company's mission is to make its innovative audio technology universally accessible, contributing to the advancement of sound amplification and overall musical enjoyment through its sophisticated production processes.

Apmonia Therapeutics

Venture Round in 2022
Apmonia Therapeutics developing a pipeline of next generation peptide based therapies targeting the tumor microenvironment to improve the lives of patients with cancer. If anyone would want to contact them please contact them via phone call or email.

Contentsquare

Series F in 2022
Contentsquare is an AI-powered platform that provides rich and contextual insight through customer behaviors, feelings, and intent. The platform helps brands to transform their businesses digitally using digital experience analytics that allows them to take action through enterprise scale and build customer trust with security, privacy, and accessibility.

Ludocare

Seed Round in 2022
Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

Flying Whales

Venture Round in 2022
Flying Whales is a French company founded in 2012, based in Suresnes, specializing in the development of large-capacity airships for the transport of heavy and oversized cargo. The company focuses on creating helium-filled, rigid-structure airships that can efficiently load and unload substantial freight from a stationary position. Utilizing small amounts of diesel and electric engines, Flying Whales aims to provide innovative solutions for transportation, logistics, and freight sectors facing infrastructure challenges. By enhancing freight transportation capabilities, the company helps clients reduce operating costs while minimizing environmental impact, effectively connecting land-locked regions to the global economy.

Healshape

Venture Round in 2022
Healshape is a biotech startup dedicated to developing natural breast reconstruction solutions for women. The company specializes in regenerative medicine, focusing on creating innovative alternatives for breast regeneration through advanced 3D bioprinting technology. Healshape's primary product is a bioprosthesis designed for breast reconstruction, which aims to empower women by helping them regain self-confidence and achieve long-lasting, aesthetically pleasing results following surgery.

Siteflow

Series A in 2022
Siteflow is a developer of cloud-based service management software tailored for complex industries such as nuclear, manufacturing, special works, and oil and gas. Founded in 2017 and headquartered in Paris, France, the company offers Siteflow Builder, an application designed to streamline operations by aiding in the preparation, execution, and monitoring of projects on-site. This software facilitates real-time progress tracking, enhances collaboration among team members, and standardizes business operations. By focusing on user-friendly interfaces and functionalities that add direct value, Siteflow addresses the unique challenges faced by regulated industries, where traditional tools have often fallen short. The company also supports organizations in their digital transformation efforts, ensuring a smooth transition towards operational excellence by redesigning workflows and improving day-to-day activities for engineers, project managers, and operators.

Osivax

Grant in 2022
Osivax is a company focused on developing immunotherapy vaccines aimed at treating infectious diseases. Its innovative vaccines enhance the uptake into dendritic cells and boost the immunogenicity of natural proteins, which triggers a more effective immune response, particularly through significant CD8 T cell activation. This technology is designed to serve as a universal vaccine, targeting not only existing but also emerging coronavirus infections, as well as other globally impactful infectious diseases. In addition to infectious diseases, Osivax's vaccines also support cancer treatment, providing medical practitioners with advanced tools to treat a range of serious health conditions effectively.

Leanspace

Debt Financing in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Strapi

Series B in 2022
Strapi is an open-source software company based in Paris, founded in 2016. It specializes in providing a headless content management system (CMS) that enables developers to efficiently build, deploy, and manage application backends with minimal effort. By decoupling the frontend from the CMS, Strapi allows developers to utilize their preferred front-end tools and frameworks while offering a robust API for content delivery across various devices. The platform features a powerful dashboard and tools for API prototyping and management, streamlining the content distribution process for editors. This flexibility and user-friendly approach position Strapi as a valuable resource for developers seeking to create dynamic and scalable applications.

Leanspace

Seed Round in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

DCbrain

Venture Round in 2022
DCbrain is a deep-tech software-as-a-service company based in Paris, France, specializing in the energy and supply chain sectors. Founded in 2014, the company provides an AI-powered optimization platform that integrates a visualization interface with a predictive analysis toolbox. This platform is designed to assist clients in identifying anomalies, preventing incidents, and forecasting the future developments of complex network configurations. By leveraging advanced artificial intelligence and Hybrid AI algorithms, DCbrain aims to enhance operational efficiency and decision-making for its users.

Scintil Photonics

Venture Round in 2022
SCINTIL Photonics is a fabless company that develops silicon photonic integrated circuits. SCINTIL solutions combine the best of Silicon (Si) and Indium Phosphide (InP) materials using wafer-scale bonding of InP on Si and rely on commercial silicon foundry processes to build fully integrated photonic circuits (comprising multi-wavelength lasers, waveguides, wavelength filters, and photodetectors).

DBV Technologies

Post in 2022
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.

Diabeloop

Debt Financing in 2022
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes. The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015 and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.

UnitySC

Venture Round in 2022
UnitySC specializes in metrology and inspection equipment for advanced semiconductor packaging and defect inspection. The company offers global service and application support to maintain equipment efficiency throughout its lifecycle. UnitySC serves various markets, including automotive, high-performance computing, and the Internet of Things, enhancing technological capabilities across industries.

Vade Secure

Venture Round in 2022
Vade Secure is the global leader on anti-phishing, spear phishing, malware and ransomware with heuristic filtering. Language independent, the filter analyzes globally all incoming emails (links, attached files, content…) to detect all threats in zero-day, even the most targeted attacks. After elimination all threats, we eliminate the nuisance of low priority emails with the Graymail Management. Ads, social networks notifications, and newsletters are automatically sent to the graymail folder while the Safe Unsubscribe button eliminate them forever. Protecting more than 500 million of mailboxes in 76 countries, our solutions are used by major ISPs, OEMs, and Enterprises worldwide. Vade Secure is implanted in 5 countries (USA, Canada, France, Hong Kong, and Japan) to offer a 24/7 support. For more information, please visit www.vadesecure.com/en.

Club Employes

Series A in 2022
Club Employes is an innovative web platform that offers hundreds of products, services at reduced prices to employees of French companies.

Sencrop

Series B in 2022
Sencrop is an ag-tech startup that provides an in-field data platform to assist farmers in making informed agricultural decisions. The company designs and sells an integrated network of connected weather forecast solutions, which include sensors that measure key parameters such as rain, humidity, and wind speed. These sensors are designed to be affordable, durable, portable, and user-friendly, facilitating more efficient and sustainable farming practices. By collecting real-time data on soil humidity and temperature, Sencrop enables farmers to optimize their operations regarding pesticide application, seeding, and irrigation, ultimately helping to save time and resources in the field.

Arianee

Series A in 2022
Arianee SA, founded in 2018 and based in Paris, France, specializes in digital certifications for products using a blockchain platform compatible with Ethereum. The company aims to enhance the authentication of branded products through a universal open-source protocol that creates an immutable ledger documenting all aspects of product creation and sales. This technology facilitates secure and transparent interactions among brands, product owners, and third-party retailers, establishing a global standard for the digital certification of valuable items. Arianee's mission extends to enriching the relationship between brands and consumers by enabling direct and ongoing engagement through digital assets, such as NFTs.

Nutripure

Private Equity Round in 2022
Nutripure is a company based in Deyme, France, focused on the development and distribution of food supplements and organic superfoods. The business offers a diverse range of products, including protein bars, whey protein shakes, and peptides, aimed at helping customers achieve their health and wellness goals. As a Digital Native Vertical Brand, Nutripure emphasizes direct engagement with consumers, ensuring accessibility and quality in its offerings.

Implicity

Series A in 2022
Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac electronic implants. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alert taking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform.

mobee travel

Series A in 2022
Mobee travel is the first holiday booking plate form dedicated to reduced mobility people. We sell more than 30'000 accessibles accomodations all around the world and each of them are checked to ensure to our traveler's that everything's will be good for their needeed. If our traveler's need to have medical equipment during their trip, we provide them on the spot before their arrival.

Dfns

Seed Round in 2022
Dfns offers a wallets-as-a-service (WaaS) platform that enables businesses to efficiently manage digital assets while ensuring high levels of security. The platform integrates seamlessly with existing systems, allowing for secure user onboarding and streamlined transactions across multiple blockchains.

Ribonexus

Debt Financing in 2022
Ribonexus is a biotechnology company dedicated to developing innovative therapies aimed at treating cancer, particularly melanoma. The company is focused on creating a pipeline of small molecules that target the eukaryotic translation Initiation Factor-4A (eIF4A), which plays a significant role in various solid and hematologic cancers. This target is particularly relevant for addressing resistance to existing treatments, which often diminishes the effectiveness of targeted therapies. Ribonexus aims to produce drugs that can restore sensitivity to these therapies in patients who have developed resistance, thereby improving treatment outcomes in oncology.

Ribonexus

Grant in 2022
Ribonexus is a biotechnology company dedicated to developing innovative therapies aimed at treating cancer, particularly melanoma. The company is focused on creating a pipeline of small molecules that target the eukaryotic translation Initiation Factor-4A (eIF4A), which plays a significant role in various solid and hematologic cancers. This target is particularly relevant for addressing resistance to existing treatments, which often diminishes the effectiveness of targeted therapies. Ribonexus aims to produce drugs that can restore sensitivity to these therapies in patients who have developed resistance, thereby improving treatment outcomes in oncology.

Phagos

Pre Seed Round in 2022
Phagos is a biotechnology company focused on developing personalized bacteriophage solutions as a sustainable alternative to traditional antibiotics. The company operates a research platform that creates customizable drugs aimed at replacing antibiotics in animal farming. By harnessing bacteriophages, which are natural predators of bacteria, Phagos seeks to provide an effective means to combat incurable and deadly infectious diseases. This innovative approach aligns with the growing need for alternatives to antibiotics in both human and veterinary medicine, addressing health challenges while promoting sustainable practices in agriculture.

Umiami

Series A in 2022
Umiami is a French food-tech startup founded in 2020 and based in Paris, focused on developing plant-based food technology aimed at reducing meat consumption. The company specializes in creating plant-based whole-cuts that utilize plant proteins, providing consumers with alternatives that closely replicate the taste, texture, and aroma of traditional meat products. By offering these innovative solutions, Umiami seeks to address the growing demand for sustainable food options while promoting healthier dietary choices.

Umiami

Series A in 2022
Umiami is a French food-tech startup founded in 2020 and based in Paris, focused on developing plant-based food technology aimed at reducing meat consumption. The company specializes in creating plant-based whole-cuts that utilize plant proteins, providing consumers with alternatives that closely replicate the taste, texture, and aroma of traditional meat products. By offering these innovative solutions, Umiami seeks to address the growing demand for sustainable food options while promoting healthier dietary choices.

LimFlow

Series D in 2022
LimFlow System is approved for sale in markets regulated by the CE Mark. Investigational device in the United States. Limited by U.S. federal law to investigational use only in the U.S. LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage chronic limb ischemia (CLI) patients, when all other revascularization efforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach.

Priothera

Debt Financing in 2022
Priothera Ltd is a clinical-stage company based in Dublin, Ireland, with an additional location in Saint Louis, France. It specializes in the development of orally applied sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. The company's primary focus is on its lead product, mocravimod, which is designed to enhance the curative potential of allogeneic haematopoietic stem cell transplants. By reducing the egress of T cell subsets from lymphatic tissues, Priothera's modulators aim to provide dual inhibition of graft versus host disease while also promoting graft versus leukemia effects, ultimately improving patient outcomes in this challenging area of medicine.

Istya

Pre Seed Round in 2022
Istya develops solutions to monitor, predict and manage indoor air quality. Our solutions have also been designed to help reduce the energy cost of ventilation systems and limit the risk of spreading viruses by air. Istya was founded in 2021 and was headquartered in Ile-de-France, France.

Cairdac

Series A in 2022
Cairdac is a medtech startup focused on developing an innovative leadless pacing system that utilizes a self-sustaining power technology. The company has achieved a significant milestone by creating the first self-sustaining pacemaker with a lifespan exceeding 15 years, leveraging a proprietary piezoelectric energy harvester in conjunction with a miniaturized power management circuit. Their unique product, the ALPS, is an autonomous and endoscopically implanted leadless pacemaker designed to harness the heart's kinetic energy for power. By integrating disruptive technologies into traditional pacemaker designs, Cairdac aims to provide a cost-effective solution that addresses the evolving needs of patients and healthcare professionals while enhancing the overall quality of life for those requiring cardiac rhythm management.

Circle Sportswear

Seed Round in 2022
Circle Sportswear is an online retailer specializing in sportswear made from recycled and recyclable materials. The company offers a diverse range of products, including t-shirts, pants, shorts, and leggings, all designed with sustainability in mind. Utilizing non-toxic and ecological fabrics such as Tencel, Circle Sportswear provides comfortable activewear that is both affordable and environmentally friendly. By focusing on a circular economy model, the company aims to reduce waste and promote responsible consumerism in the fashion industry.

Deepki

Series C in 2022
Deepki is a company that aids real estate stakeholders in their transition towards sustainability and achieving net zero goals. It provides a comprehensive data intelligence platform designed to digitalize the management of large property portfolios. By aligning the interests of various stakeholders, Deepki helps formulate efficient strategies that transform real estate into a beneficial force for the environment. The platform enhances knowledge of assets, enabling clients to streamline management processes while identifying potential energy and cost savings. Additionally, Deepki offers expert advisory services to further improve environmental, social, and governance (ESG) performance, thereby increasing the overall value of real estate assets.

Kayrros

Venture Round in 2022
Kayrros is a leading advanced data analytics company that specializes in providing actionable insights for the global energy market. With a team of over 100 employees from more than 15 nationalities, Kayrros operates from its headquarters in Paris and has additional offices in Houston, London, New York, and Singapore. The company integrates alternative and market data to create unique product offerings that enhance decision-making across the energy sector. Its platform focuses on environmental intelligence and asset observation, delivering critical insights related to greenhouse gas reduction, ecosystem protection, and energy transition management. Kayrros aims to support governments, companies, and investment markets in assessing the climate impact of energy and industrial activities, thereby enabling faster and more informed decisions. The company’s solutions are designed to be scalable and continuously expand to include new geographic regions and data sources, enhancing transparency in energy markets worldwide.

Vaxxel

Seed Round in 2022
Vaxxel is an Innovative viral live-attenuated platform that develops novel and proprietary live-attenuated vaccine candidates against bronchiolitis and pneumonia caused by pneumovirus.

Brenus Pharma

Seed Round in 2022
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.

Konect

Pre Seed Round in 2022
Konect helps users to create their own website and centralises all online content in one place and makes easy to share with community.

Archeon

Series A in 2022
Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients in prehospital care.

K-Ryole

Series B in 2022
K-Ryole is a privately held company that specializes in the manufacture of smart electric bike trailers designed for cyclists. These innovative trailers can be attached to any bicycle and are capable of carrying heavy loads, making them suitable for urban transportation. By offering a practical solution for goods transport, K-Ryole aims to help riders reduce their carbon footprint while also lowering logistics costs.

Doctolib

Series F in 2022
Doctolib is an online healthcare booking platform and management software provider. For doctors, Doctolib offers a full-range service to improve bookings management, reduce no-show, and bring new patients to their office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctors or dental appointments 24/7 within a few clicks. Founded in 2013, Doctolib is based in Paris, France.

SeaBeLife

Grant in 2022
SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Alice & Bob

Series A in 2022
Alice&Bob build Universal, Error-free, Quantum Computers to help industries and researchers solve the hardest problems.

FidéCoin by FideClub

Debt Financing in 2022
RetailTech that offers the first loyalty currency on WhatsApp. We enable local businesses to join a loyalty program to allow their customers to earn FidéCoins when they make purchases. Everything happens on WhatsApp which allows the million users to have access to FidéCoin. We are incubated by Le Village by CA

Flowlity

Seed Round in 2022
Flowlity is a provider of supply chain management software aimed at improving inventory management for businesses. Founded in 2018, the company addresses the significant losses associated with poor inventory practices by offering solutions that enhance resilience in supply chain planning. Utilizing a combination of artificial intelligence and optimization techniques, Flowlity's platform helps organizations manage stock levels and replenishment in real-time, allowing them to visualize order status and inventory levels effectively. Its innovative approach has been successfully implemented by notable clients, including Danone, La Redoute, Saint Gobain, and Camif, leading to an average reduction of 30% in inventory levels and 20% in shortages. By enabling companies to transition from a deterministic model to a more adaptable planning strategy, Flowlity aims to mitigate the uncertainties that often plague supply chains.

Tenacy

Seed Round in 2022
Tenacy is a developer of a cloud-based software platform focused on compliance and risk management, specifically in the context of cybersecurity. The platform enables organizations to assess and define risks, manage incidents, and track deviations effectively. It provides tools for creating dashboards, benchmarking data, and offering decision support, allowing companies to enhance their cybersecurity governance. By fostering collaboration, Tenacy's software helps businesses measure performance and report on security services, ultimately aiming to protect and strengthen their operations through tailored risk management solutions.

Kyotherm

Venture Round in 2022
Kyotherm is an investment company that focuses on financing renewable heat production and energy efficiency projects. The company provides equity investment services to energy service providers, engineering firms, developers, heat consumers, and equipment manufacturers, assisting them in securing third-party financing for their initiatives. Kyotherm specializes in acquiring majority stakes in green energy generation projects, including geothermal and biomass heating plants, as well as district heating networks. By facilitating project capital, Kyotherm enables clients to develop diverse energy infrastructures while enhancing the contractual and financial structuring of these projects.

Lisaqua

Seed Round in 2022
Lisaqua is developing a unique aquaculture process to raise prawns without antibiotics and without polluting waste

Susu

Debt Financing in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

Susu

Grant in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

CarbonWorks

Series A in 2022
CarbonWorks is specialising in the use of microalgae to capture and utilise carbon dioxide.

Kubo Labs

Pre Seed Round in 2022
94 % of organizations have experienced a serious security issue in the last 12 months and cluster misconfiguration is the leading cause ("Kubernetes adoption, security, and market trends report" by Redhat, July 2021). For 68% of the organizations, Kubernetes-related bills are going up ("FinOps for Kubernetes", CNCF report, June 2021). With Kubo Labs, we make sure that won't happen thanks to a series of products that embedded best-practices.

Cell-Easy

Funding Round in 2022
Cell-Easy SAS is a contract development and manufacturing organization based in Toulouse, France, specializing in stem cell services for preclinical and clinical drug development. Founded in 2017, the company focuses on providing ready-to-inject adipose-derived allogeneic stem cells, utilizing biological material from healthy donors. This approach enables the healthcare industry to reduce manufacturing costs associated with stem cell therapies, addressing affordability challenges in the field. By streamlining access to these stem cells, Cell-Easy supports various development projects aimed at improving patient outcomes.

Specify

Seed Round in 2022
Specify helps companies manage their brand identity, by collecting, storing, and distributing their design tokens and assets — automatically. Specify was founded in Paris (France) in 2018 by Valentin Chrétien, Pierre-Antoine Lemaître, Antoine Moreaux, and Louis Chenais. Formerly designers, product managers, and developers, these 4 co-founders decided to create Specify in order to revolutionize the way to maintain a brand's identity through different digital products. After 2 years of bootstrapping, and more than 1,000 international teams onboarded, Specify raises a $1m pre-seed with 360 Capital, BPI Seed Ventures, and Seedcamp. A few months later, Specify positions itself as the category leader for DesignOps and Design Systems by being the first Design Data Platform. In parallel, Specify is a member of the DTCG (Design Tokens Community Group) whose goal is to provide standards upon which products and design tools can rely for sharing stylistic pieces of a design system at scale.

Tracktor

Venture Round in 2022
Tracktor is a web-based platform that facilitates the rental and purchase of construction equipment for building and civil engineering professionals. It aggregates various rental companies across France, allowing users to find and compare equipment options efficiently. The platform enables construction workers to obtain instant quotes and book a range of equipment, including mini-excavators, platforms, trolleys, barriers, and living bases, all in a few clicks. By streamlining the rental process, Tracktor provides favorable conditions for customers, regardless of their rental volume, enhancing accessibility and convenience in the construction industry.

Gouach

Seed Round in 2022
Gouach is a manufacturer of a revolutionary eco-designed battery that can be repaired at mega-speed.

Alma

Series C in 2022
Alma is a provider of installment-based payments through a large merchant network. It let customers pay in installments or later online or in-store.

Traxens

Venture Round in 2022
TRAXENS delivers the world's most exhaustive, precise and timely information on containers and container transporters allowing all stakeholders in multi-modal transport to improve costs, optimize investment, and offer premium services. To attain this performance TRAXENS led a 3-year R&D program to develop specific technology required to produce cost effective, durable and autonomous devices for a wide range of container data capture and real-time transmission of this data from anywhere on the globe.

Silvr

Series A in 2022
Silvr reinvents the way entrepreneurs get funded. Financing businesses has not evolved over the last decades: banks prefer to fund assets, and equity is not the best fit for all. Silvr enables entrepreneurs by building a world where funding is easy to access, scalable, and equity-free. Silvr leverages digital business data to predict future revenues and offer funding in 24 hours. Silvr is headquartered in Paris, is backed by ISAI and Eurazeo, and deploys millions of euros of funding for European entrepreneurs every month.

Elicit Plant

Series A in 2022
Elicit Plant is an agro-biotech company focused on enhancing the resilience of crops to water stress and developing phytosterol-based solutions. By leveraging proprietary technology, Elicit Plant aims to address the challenges posed by climate change on agriculture. The company’s products are designed to improve plant stress resistance and activate natural defenses, which has been validated through extensive field trials across three continents. These trials demonstrate that Elicit Plant's biosolutions provide farmers with consistent and significant returns on investment, positioning the company as a leader in the ecological transition within the agricultural sector.

Combo

Series A in 2022
Combo is a staff planning and staff management software.

Ascor Communication

Venture Round in 2022
Ascor Communication is a holding company with private and family shareholders whose vocation is to invest in digital and distance learning.

Cureety

Series A in 2022
Cureety is a telemedicine startup focused on enhancing the follow-up and care of cancer patients through its healthcare telemonitoring platform. The platform provides tools that support healthcare professionals in adjusting cancer treatments and collecting real-world data. This data collection not only aids in better patient care but also contributes to research initiatives, allowing researchers and industry stakeholders to advance their understanding and treatment of cancer. By transforming the care pathway for cancer patients, Cureety aims to improve overall patient outcomes and foster ongoing research programs in the field.

Sextant

Series B in 2022
Sextant is a network of independent real estate agents specializing in property sales in France. With a strong focus on enhancing the customer experience, Sextant streamlines the purchasing process by managing all legal and financial aspects involved, ensuring a straightforward and stress-free experience for buyers and sellers. The company leverages technology by developing applications and websites that facilitate the work of its agents, reflecting its commitment to advancing the French Proptech sector. With less than a decade in the market, Sextant has established itself as a leader in real estate agent networks, effectively guiding clients from initial contact through to the signing of sale agreements at the notary.

Starkage Therapeutics

Venture Round in 2022
Starkage Therapeutics is a discovery-stage biotechnology company focused on improving the quality of life for patients suffering from various health conditions. The company is developing a platform that targets the depletion of senescent cells, which are linked to age-related diseases, through a combination of immunotherapy and cancer treatment approaches. Starkage Therapeutics aims to address unmet medical needs in areas such as idiopathic pulmonary fibrosis, neurodegenerative diseases, and metabolic dysfunction or hepatic fibrosis. Through its innovative research and therapeutic strategies, the company seeks to enhance patient health and treatment outcomes.

NAWA Technologies

Series C in 2022
NAWA Technologies focuses on developing innovative energy solutions through its Ultra Fast Carbon Battery Technology, which utilizes carbon as a primary material due to its abundance and accessibility. Established in April 2013, the company is dedicated to enhancing energy conversion, storage, and efficiency while minimizing environmental impacts through sustainable manufacturing processes. With over 15 years of research and development in nanomaterials, NAWA Technologies has built a pilot production line and employs a team of 24 professionals. Its products, including advanced ultracapacitors and battery electrodes, are designed to facilitate the integration of renewable energy into smart grids, promoting efficient electricity storage and reducing carbon emissions associated with fossil fuel usage.

Wandercraft

Series C in 2022
Wandercraft specializes in the development and sale of advanced exoskeletons that enable individuals with mobility impairments to walk independently. Its flagship product, Atalante, is the first exoskeleton designed for self-balanced walking, providing a realistic gait without the need for crutches or other aids. Since receiving CE-mark approval in 2019, Atalante has been utilized in European rehabilitation hospitals to assist with gait re-learning therapies. The company is also pursuing FDA approval for its technology. Additionally, Wandercraft is working on a more compact and agile Personal Mobility exoskeleton intended for everyday use. By integrating expertise in algorithmics, artificial intelligence, robotics, and clinical applications, Wandercraft aims to create innovative solutions that enhance the autonomy and quality of life for individuals with mobility challenges.

Figures

Venture Round in 2022
Figures offers a real-time compensation intelligence platform tailored for the startup and scale-up market, with a focus on European venture-backed companies. The platform provides reliable data on compensation and gender diversity, enabling clients to access comprehensive salary information categorized by job title and seniority level. Clients can filter this data based on company headcount and funding status, allowing for meaningful comparisons and insights. By streamlining the process of gathering and analyzing compensation data, Figures helps companies save time and make informed decisions regarding employee remuneration.

Exotec

Series D in 2022
Exotec specializes in the design and manufacture of automated storage and retrieval systems, particularly the SKYPOD solution, which enhances order preparation in retail logistics across various sectors. The SKYPOD is a robotic order picking system that also functions as a buffer for prepared orders, suitable for both cool and ambient environments. The company customizes its solutions to meet the specific automation levels and logistics needs of its clients, ensuring optimal performance and flexibility. By utilizing a fleet of collaborative mobile robots, Exotec's technology streamlines the transport and sorting of goods within warehouses, reducing travel distances and optimizing space. This approach allows businesses to efficiently scale their operations by easily adding more robots, stations, or racks as needed, all while maintaining uninterrupted production.

Heroic sante

Seed Round in 2022
Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.

PayFit

Series E in 2022
PayFit is a technology company that specializes in simplifying and automating payroll and human resource processes for small and medium-sized businesses. Its software streamlines payroll management and handles social statements while providing a flexible HR system to monitor working hours, onboarding, leave requests, and expense reports. By offering a comprehensive online platform, PayFit enables businesses to manage all payroll and HR information efficiently and effectively. The company also supports the digital transformation of organizations through an expanding array of product features and services, complemented by the assistance of payroll experts to enhance user experience.

Groupe SFC

Venture Round in 2022
• A team of 200 employees including 18 associates, providing daily guidance to more than 5000 clients • 9 locations in France • Our policy is geared towards quality and customer satisfaction • Understanding of technology which guarantees the use of high-performance and specialised solutions • Experts to drive forward your performance, at all stages of your company’s life • In 2012, turnover of close to €14.5m

Pherecydes Pharma

Grant in 2022
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Stern Tech

Seed Round in 2022
We created a revolutionary SaaS platform for human behavior analysis: AI x Psychology to understand human behavior in real time. Use cases: Marketing, Education, eMeetings, Healthcare, Automotive, Retail, Sport. See our partnership with Renault and STMicroelectronics : https://stern.consulting/sterntech-h1stvision.mp4

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Kovalee

Seed Round in 2021
Kovalee is a mobile app publisher that supports app creators by providing a comprehensive application publishing platform. The company partners with app owners to elevate their apps in the marketplace, offering services such as product enhancement, user acquisition, monetization, and app store optimization. Kovalee's platform features modular design and application testing, enabling developers to focus on content and code while leveraging data-driven strategies. Additionally, the company employs artificial intelligence to predict customer behavior, helping developers optimize their apps for better performance and profitability.

Depixus

Series A in 2021
Depixus is a biotechnology company that has developed a novel technology designed for real-time analysis of individual biomolecular interactions at a large scale. Its platform enables comprehensive genome analysis, allowing researchers to examine entire genomic regions quickly and efficiently. This integrated system provides the flexibility to specify the desired level of sequence and epigenetic detail, facilitating the discovery of new biological pathways and the decoding of disease mechanisms. By enhancing the understanding of these processes, Depixus aims to contribute to the development of new precision medicines. The company's focus on advanced DNA and RNA sequencing technologies addresses the limitations of current methods, particularly in achieving single-molecule precision.

Meiogenix

Series A in 2021
Meiogenix is a biotechnology company focused on developing innovative breeding technologies aimed at unlocking the untapped genetic diversity of various organisms. By modulating the frequency of homologous recombination in eukaryotic cells, the company enhances natural biodiversity. This approach enables the creation of new products that can help tackle pressing global food and industrial challenges. Through its advancements, Meiogenix contributes to the exploration and application of genetic resources, ultimately aiming to improve agricultural and industrial outputs.

Uavia

Venture Round in 2021
Uavia is a technology company founded in 2015 and based in Vitry-sur-Seine, Ile-de-France, specializing in cloud-based robotic solutions. The company enables industries to manage and control autonomous fleets of drones and robots through a collaborative platform that incorporates artificial intelligence. This technology allows multiple users worldwide to supervise heterogeneous fleets in real time, facilitating data processing, analysis, and sharing for various applications. Uavia's platform is particularly useful for conducting aerial inspections and surveillance in industrial environments, enhancing operational efficiency and oversight over long distances.

SPARTHA Medical

Seed Round in 2021
SPARTHA Medical is a medical technology company focused on developing innovative coatings that enhance the safety of medical devices and consumer products by protecting against microbial and inflammatory risks. The company utilizes natural biopolymers to create invisible, eco-friendly, and biocompatible coatings that possess antibacterial, antiviral, and anti-inflammatory properties. By employing a patented technology that allows for the precise control of the assembly of two different polyelectrolytes, SPARTHA Medical's products can be tailored to meet diverse requirements across various fields. These multifunctional and easy-to-apply coating solutions aim to help healthcare institutions maintain disease-free surfaces on medical devices, thereby enhancing patient safety and reducing infection risks.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.